Advertisement

Topics

STAT Plus: Sage Therapeutics drug reduces postpartum depression in two late-stage clinical trials

07:36 EST 9 Nov 2017 | STAT

Sage Therapeutics reported positive results Thursday from clinical trials of its lead drug brexanolone in women suffering from postpartum depression.

Original Article: STAT Plus: Sage Therapeutics drug reduces postpartum depression in two late-stage clinical trials

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Sage Therapeutics drug reduces postpartum depression in two late-stage clinical trials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...